McKesson Ventures and Medidata Solutions participated in a round that will help the medical data provider in the fight against rare diseases.

AllStripes, the US-based disease research software developer formerly called RDMD, has closed a $50m series B round featuring design software provider Dassault Systèmes and medical supplies distributor McKesson.

Venture capital firm Lux Capital led the round and was also joined by Jazz Venture Partners, Spark Capital, Maveron and private investors Arif Nathoo and Leila Zegna, while McKesson and Dassault invested through subsidiaries McKesson Ventures and Medidata Solutions respectively.

Founded in 2017, AllStripes provides a research platform where patients with rare…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn